Paxman AB (publ)

DB:B0F Stock Report

Market Cap: €114.0m

Paxman Past Earnings Performance

Past criteria checks 5/6

Paxman has been growing earnings at an average annual rate of 42.6%, while the Medical Equipment industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 25.1% per year. Paxman's return on equity is 17.4%, and it has net margins of 10.4%.

Key information

42.6%

Earnings growth rate

41.6%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate25.1%
Return on equity17.4%
Net Margin10.4%
Next Earnings Update21 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Paxman makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:B0F Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2425326650
30 Jun 2424829640
31 Mar 2423624610
31 Dec 232218590
30 Sep 232081580
30 Jun 23188-2550
31 Mar 23173-7530
31 Dec 22157-10490
30 Sep 22143-2730
30 Jun 22125-12700
31 Mar 22111-18650
31 Dec 21105-13620
30 Sep 2193-23610
30 Jun 2187-21570
31 Mar 2180-22540
31 Dec 2083-19540
30 Sep 2090-6560
30 Jun 2096-1560
31 Mar 201026580
31 Dec 19963570
30 Sep 1990-4500
30 Jun 1983-5490
31 Mar 1975-6470
31 Dec 1869-7460
30 Sep 1858-9370
30 Jun 1850-10350
31 Mar 1843-9330
31 Dec 1736-7310

Quality Earnings: B0F has high quality earnings.

Growing Profit Margin: B0F's current net profit margins (10.4%) are higher than last year (0.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: B0F has become profitable over the past 5 years, growing earnings by 42.6% per year.

Accelerating Growth: B0F's earnings growth over the past year (4243.6%) exceeds its 5-year average (42.6% per year).

Earnings vs Industry: B0F earnings growth over the past year (4243.6%) exceeded the Medical Equipment industry 10.1%.

Return on Equity

High ROE: B0F's Return on Equity (17.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 13:43
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Paxman AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mats HyttingeRedeye